EEG Microstates Across At-Risk Mental States
NCT06045897
Summary
The goal of this observational study is to compare subjects with at-risk-mental-state, early psychosis, schizophrenia, depression, and autism spectrum disorders, with healthy controls (N = 21 x 6). The main questions it aims to answer are: * are EEG microstate anomalies associated with diagnosis, clinical and functional prognosis, both in resting conditions and during sleep ? * are EEG microstates anomalies associated with differences in sensorimotor integration, prosodic and conversational, interoceptive, and narrative self ? * an ancillary study will be to see whether in healthy controls EEG microstate properties vary under light hypnosis conditions. Participants will: * undergo deep phenotyping based on psychopathology and neuropsychological assessments * undergo a high-resolution EEG (64 electrodes) with a resting period and a sensorimotor task; and healthy controls will have a light hypnosis period. * undergo a recording of the characteristics of their voice (tone, prosody) * undergo a one-night polysomnography * undergo MRI and biological sampling for multi-omic analyses * undergo a virtual reality experience
Eligibility
Inclusion Criteria: * age between 15 and 30 years * subjects meeting CAARMS criteria for stage Ia or Ib mental states at risk (for stage Ia, mild or nonspecific symptoms of psychosis or severe mood disorder, and mild functional impairment; for stage Ib, moderate symptoms below intervention threshold and moderate functional impairment) * subjects meeting any DSM-5 criteria associated with a first onset of psychotic symptoms (first episode psychosis) * subjects satisfying DSM-5 criteria for depressive disorder * subjects meeting DSM-5 criteria for autism spectrum disorder * healthy control subjects recruited from the general population Exclusion Criteria: * suicidal risk * severe or non-stabilized somatic and neurological disorders * epilepsy * head trauma * IQ below 70 * for healthy control subjects, a family history of psychosis is an exclusion criterion * bipolar disorder * obsessive-compulsive disorder * substance use disorder, except for cannabis, tolerated up to 5 joints/day.
Conditions5
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
NCT06045897